Published :
Tables : 100
Figures : 30
Category : Healthcare
No. of Pages : 220
Report Code : HC-1153
Fluoroscopy Equipment Market Introduction Fluoroscopy Equipment Market is estimated to value over USD 7.6 billion by 2027 end and is expected to register a CAGR of over 4.2% from the forecast period 2020-2027. The main factors driving the growth of the market are the benefits of FPDs over image intensifiers, increasing geriatric population, awareness activities, rising cases of chronic diseases and the use of fluoroscopy in pain management. In addition, the favorable reimbursement policy for analog radiography systems is augmenting the market growth. The rapid adoption of hand-held fluoroscopes due to its efficient facilities is creating a lucrative opportunity for the manufacturers. The market is classified into product, application, and region. Based on products, fluoroscopy systems are expected to dominate the market. The technological advancements in fixed C-arms and growing use of fluoroscopic imaging for interventional procedures and imaging for diagnosis is spurring the market. Fluoroscope systems offer various benefits such as radiation sensitivity, optical magnification, and high portability. Furthermore, they provide better clarity and stability of images. Other advantages for opting fluoroscope systems are high portability, optical magnification, x-ray recording capability and real-time tracking of images. Such factors have bolstered the market. Based on application, surgical applications is expected to hold vast shares of the market. Surgical applications consist of orthopaedic & trauma, cardiovascular, neurosurgeries and gastrointestinal surgeries. Growing prevalence of cardiovascular diseases has led to a demand for highly efficient diagnostic imaging tools. Fluoroscopy is most frequently performed with procedures such as coronary angiography, radiographic catheter ablation, and diagnosis electrophysiology studies. The growing number of conferences and exhibitions by prominent players and manufacturers to promote fluoroscopy instruments is stimulating the market. The growing importance of anatomy visualization in emergency medicine is also driving the market. Fluoroscopy facilities can be used during cardiac catheterization since it performs as an adjunct to examine the presence of arterial blockages. Based on regions, North America dictates the market growth. Government initiatives to promote efficient treatment facilities is boosting the presence of the market in the region. For example, the FDA launched an initiative to reduce the radiation exposure of medical imaging. The initiative has resulted in an enhanced and efficient treatment for multiple surgeries. Growing preference of private and public healthcare organizations to promote advanced imaging instruments is resulting in more adoption of fluoroscopy instruments in the region. The rising number of obese population coupled with growing inclination towards minimally invasive surgeries have stimulated the market in the region. Asia-Pacific region is also expected to show substantial growth owing to the strong economic development of countries like China and India. The growing number of geriatric population in nations like China and Japan is playing an instrumental role in the expansion of the market in the region. Major players of the market are: Hologic, Carestream Health, Adani Systems, Agfa-Gevaert Group, Hitachi, Ziehm Imaging, Philips, GE Healthcare, Siemens Healthineers, Shimadzu and Lepu Medical Technology. Fluoroscopy Equipment Market Segmentation: By Product Fixed C-arms Fluoroscopy Systems Mobile C-arms By Application Diagnostic Applications Cardiology Gastroenterology Urology & Nephrology Surgical Applications Orthopedic & Trauma Surgeries Neo Surgeries Cardiovascular Surgeries Gastrointestinal Surgeries By Region North America Europe Asia Pacific Latin America Middle East & Africa Competitive Landscape: Product launches are bolstering the market. Siemens Healthineers launched Artis icono biplane in 2019. The Artis icono biplane is an angiography system which consists of special functions for neuroradiology Strategic collaborations aiming towards the advancements of the latest products is propelling the market. GE Healthcare signed a 7-year collaborative agreement with Temple University Health System to expand services related to radiology. The collaboration played an important role in eliminating restraints like cost control and reimbursement related to medical imaging. FutureWise Key Takeaways Latest technological advancements in the form of rotational angiography, flat-panel detector integrated with computed tomography will play an instrumental role in the expansion of the market Surgical procedures are expected to grow substantially owing to benefits such as higher visibility, dose reduction, and minimal trauma and invasion Orthopedics segment is anticipated to witness substantial growth owing to the rising adoption of fluoroscopy instruments in urgent care clinics, imaging centers, and orthopedic clinics Objectives of the Study: To provide with an exhaustive analysis on the global fluoroscopy equipment market by product, by application and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financial and core competencies
Fluoroscopy Equipment Market is estimated to value over USD 7.6 billion by 2027 end and is expected to register a CAGR of over 4.2% from the forecast period 2020-2027.
The main factors driving the growth of the market are the benefits of FPDs over image intensifiers, increasing geriatric population, awareness activities, rising cases of chronic diseases and the use of fluoroscopy in pain management. In addition, the favorable reimbursement policy for analog radiography systems is augmenting the market growth. The rapid adoption of hand-held fluoroscopes due to its efficient facilities is creating a lucrative opportunity for the manufacturers.
The market is classified into product, application, and region. Based on products, fluoroscopy systems are expected to dominate the market. The technological advancements in fixed C-arms and growing use of fluoroscopic imaging for interventional procedures and imaging for diagnosis is spurring the market. Fluoroscope systems offer various benefits such as radiation sensitivity, optical magnification, and high portability. Furthermore, they provide better clarity and stability of images. Other advantages for opting fluoroscope systems are high portability, optical magnification, x-ray recording capability and real-time tracking of images. Such factors have bolstered the market.
Based on application, surgical applications is expected to hold vast shares of the market. Surgical applications consist of orthopaedic & trauma, cardiovascular, neurosurgeries and gastrointestinal surgeries. Growing prevalence of cardiovascular diseases has led to a demand for highly efficient diagnostic imaging tools. Fluoroscopy is most frequently performed with procedures such as coronary angiography, radiographic catheter ablation, and diagnosis electrophysiology studies. The growing number of conferences and exhibitions by prominent players and manufacturers to promote fluoroscopy instruments is stimulating the market. The growing importance of anatomy visualization in emergency medicine is also driving the market. Fluoroscopy facilities can be used during cardiac catheterization since it performs as an adjunct to examine the presence of arterial blockages.
Based on regions, North America dictates the market growth. Government initiatives to promote efficient treatment facilities is boosting the presence of the market in the region. For example, the FDA launched an initiative to reduce the radiation exposure of medical imaging. The initiative has resulted in an enhanced and efficient treatment for multiple surgeries. Growing preference of private and public healthcare organizations to promote advanced imaging instruments is resulting in more adoption of fluoroscopy instruments in the region. The rising number of obese population coupled with growing inclination towards minimally invasive surgeries have stimulated the market in the region. Asia-Pacific region is also expected to show substantial growth owing to the strong economic development of countries like China and India. The growing number of geriatric population in nations like China and Japan is playing an instrumental role in the expansion of the market in the region.
Major players of the market are:
Hologic, Carestream Health, Adani Systems, Agfa-Gevaert Group, Hitachi, Ziehm Imaging, Philips, GE Healthcare, Siemens Healthineers, Shimadzu and Lepu Medical Technology.
Fluoroscopy Equipment Market Segmentation:
By Product
By Application
By Region
Competitive Landscape:
FutureWise Key Takeaways
Objectives of the Study:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Fluoroscopy Equipment Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Fluoroscopy Equipment Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Fluoroscopy Equipment Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Fluoroscopy Equipment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Fluoroscopy Equipment Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Fixed C-arms 7.2. Fluoroscopy Systems 7.3. Mobile C-arms 8. Global Fluoroscopy Equipment Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Diagnostic Applications 8.1.1. Cardiology 8.1.2. Gastroenterology 8.1.3. Urology & Nephrology 8.2. Surgical Applications 8.2.1. Orthopedic & Trauma Surgeries 8.2.2. Neo Surgeries 8.2.3. Cardiovascular Surgeries 8.2.4. Gastrointestinal Surgeries 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. Hologic 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Carestream Health 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Adani Systems 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Agfa-Gevaert Group 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Hitachi 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. Ziehm Imaging 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Philips 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. GE Healthcare 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. Siemens Healthineers 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. Shimadzu 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11. Lepu Medical Technology. 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics